In CRC specifically, MTERF3 has been implicated in the upregulation of pro-inflammatory cytokines such as IL-6 as well as IL-11, that not only modulate tumor growth but also enhance resistance to radiotherapy (243). This evidence concerns the gene MTERF3 and neoplasm.